Literature DB >> 3418328

Profiles of aggression among psychiatric patients. II. Covariates and predictors.

S R Kay1, F Wolkenfeld, L M Murrill.   

Abstract

An Aggression Risk Profile was developed as an objective multidimensional scale for characterizing aggressive psychiatric patients and predicting verbal, physical, and general manifestations of aggression. Based on earlier studies, the 39-item Aggression Risk Profile incorporated demographic, diagnostic, historical, and clinical parameters. Its reliability, discriminative validity, and predictive validity were supported in its application to a total of 208 inpatients. Aggressive patients were more often found to be men, to be diagnosed with organic mental syndrome or substance abuse disorder, and to be notable in history of aggression. They tended to be angry and excitable but not more floridly ill than control subjects. The contemporaneous covariates of aggression, however, were not the same as the predictors, as determined by 3-month prospective follow-up. Twelve significant predictors were identified, and multiple regression analysis revealed different sets of measures that explain 45.0% to 52.5% of the variance for verbal, physical, and total aggression. The most reliable predictors were younger age, shorter length of illness, hostility, depression, anger, and difficulty in delaying gratification. We concluded that prediction is augmented by the combination of clinical and nonclinical predictors, and we discussed likely sources of disparity in previous research.

Entities:  

Mesh:

Year:  1988        PMID: 3418328     DOI: 10.1097/00005053-198809000-00008

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  15 in total

1.  Assailant and victim behaviors immediately preceding inpatient assault.

Authors:  Martha L Crowner; Gordana Peric; Franko Stepcic; Seungyeoun Lee
Journal:  Psychiatr Q       Date:  2005

2.  Gender differences in emotional risk for self- and other-directed violence among externalizing adults.

Authors:  Naomi Sadeh; Shabnam Javdani; M Sima Finy; Edelyn Verona
Journal:  J Consult Clin Psychol       Date:  2011-02

3.  Evaluation and Treatment of the Angry Patient.

Authors:  Fallon Chipidza; Rachel S Wallwork; Traci N Adams; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2016-06-23

4.  Aggressive and violent behavior in a population of psychiatric inpatients.

Authors:  M Raja; A Azzoni; L Lubich
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-10       Impact factor: 4.328

5.  Prevalence and determinants of aggressive behavior among adults with problematic substance use in Northwest Ethiopia: a cross-sectional survey.

Authors:  Getasew Legas; Habte Belete; Sintayehu Asnakew
Journal:  BMC Psychiatry       Date:  2022-06-15       Impact factor: 4.144

6.  Serum cholesterol and aggression in hospitalized male forensic patients.

Authors:  M Hillbrand; R T Spitz; H G Foster
Journal:  J Behav Med       Date:  1995-02

7.  Revisiting the validity of measures of social cognitive bias in schizophrenia: Additional results from the Social Cognition Psychometric Evaluation (SCOPE) study.

Authors:  Benjamin E Buck; Amy E Pinkham; Philip D Harvey; David L Penn
Journal:  Br J Clin Psychol       Date:  2016-05-11

8.  Hostility and violence of acute psychiatric inpatients.

Authors:  Michele Raja; Antonella Azzoni
Journal:  Clin Pract Epidemiol Ment Health       Date:  2005-07-29

9.  No evidence of an association between A218C polymorphism of the tryptophan hydroxylase 1 gene and aggression in schizophrenia in a Korean population.

Authors:  Youl-Ri Kim; Joo Young Lee; Sung Kil Min
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

10.  Mental capacity and psychiatric in-patients: implications for the new mental health law in England and Wales.

Authors:  Gareth S Owen; George Szmukler; Genevra Richardson; Anthony S David; Peter Hayward; James Rucker; Duncan Harding; Matthew Hotopf
Journal:  Br J Psychiatry       Date:  2009-09       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.